These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 12390200)

  • 1. Review of fexofenadine in the treatment of chronic idiopathic urticaria.
    Kawashima M; Harada S; Tango T
    Int J Dermatol; 2002 Oct; 41(10):701-6. PubMed ID: 12390200
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fexofenadine HCl is safe and effective for treatment of chronic idiopathic urticaria.
    Nelson HS; Reynolds R; Mason J
    Ann Allergy Asthma Immunol; 2000 May; 84(5):517-22. PubMed ID: 10831005
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A double-blind, placebo-controlled trial of fexofenadine HCl in the treatment of chronic idiopathic urticaria.
    Finn AF; Kaplan AP; Fretwell R; Qu R; Long J
    J Allergy Clin Immunol; 1999 Nov; 104(5):1071-8. PubMed ID: 10550755
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fexofenadine: a review of its use in the management of seasonal allergic rhinitis and chronic idiopathic urticaria.
    Simpson K; Jarvis B
    Drugs; 2000 Feb; 59(2):301-21. PubMed ID: 10730552
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Once-daily fexofenadine treatment for chronic idiopathic urticaria: a multicenter, randomized, double-blind, placebo-controlled study.
    Kaplan AP; Spector SL; Meeves S; Liao Y; Varghese ST; Georges G
    Ann Allergy Asthma Immunol; 2005 Jun; 94(6):662-9. PubMed ID: 15984599
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Chronic idiopathic urticaria: effectiveness of fexofenadine. A double-blind, placebo controlled study with 21 patients].
    Degonda M; Pichler WJ; Bircher A; Helbling A
    Praxis (Bern 1994); 2002 Apr; 91(15):637-43. PubMed ID: 12014063
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the efficacy of olopatadine and fexofenadine in chronic idiopathic urticaria patients: a crossover study.
    Tanizaki H; Yamamoto Y; Nakamizo S; Otsuka A; Miyachi Y; Kabashima K
    Pharmacology; 2015; 95(1-2):32-5. PubMed ID: 25592003
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multicenter study of the efficacy and safety of fexofenadine 60 mg. twice daily in 108 Thai patients with chronic idiopathic urticaria.
    Kulthanan K; Gritiyarangsan P; Sitakalin C; Charuwichitratana S; Korkij W; Aunhachoke K; Janjumratsang P; Jiamton S; Kuntiranont M; Krisadapong J; Gherunpong N; Kullavanijaya P
    J Med Assoc Thai; 2001 Feb; 84(2):153-9. PubMed ID: 11336071
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative efficacy of cetirizine and fexofenadine in the treatment of chronic idiopathic urticaria.
    Handa S; Dogra S; Kumar B
    J Dermatolog Treat; 2004 Jan; 15(1):55-7. PubMed ID: 14754652
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the efficacy of fexofenadine 120 and 240 mg/day on chronic idiopathic urticaria and histamine-induced skin responses in Japanese populations.
    Tanizaki H; Nakahigashi K; Miyachi Y; Kabashima K
    J Dermatolog Treat; 2013 Dec; 24(6):477-80. PubMed ID: 23534896
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of fexofenadine hydrochloride on productivity and quality of life in patients with chronic idiopathic urticaria.
    Spector SL; Shikiar R; Harding G; Meeves S; Leahy MJ
    Cutis; 2007 Feb; 79(2):157-62. PubMed ID: 17388220
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Addition of fexofenadine to a topical corticosteroid reduces the pruritus associated with atopic dermatitis in a 1-week randomized, multicentre, double-blind, placebo-controlled, parallel-group study.
    Kawashima M; Tango T; Noguchi T; Inagi M; Nakagawa H; Harada S
    Br J Dermatol; 2003 Jun; 148(6):1212-21. PubMed ID: 12828751
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of fexofenadine versus desloratadine in suppressing histamine-induced wheal and flare.
    Meltzer EO; Gillman SA
    Allergy Asthma Proc; 2007; 28(1):67-73. PubMed ID: 17390761
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Levocetirizine for the treatment of allergic rhinitis and chronic idiopathic urticaria in adults and children.
    Singh-Franco D; Ghin HL; Robles GI; Borja-Hart N; Perez A
    Clin Ther; 2009 Aug; 31(8):1664-87. PubMed ID: 19808127
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The systemic safety of fexofenadine HCl.
    Mason J; Reynolds R; Rao N
    Clin Exp Allergy; 1999 Jul; 29 Suppl 3():163-70; discussion 171-3. PubMed ID: 10444232
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fexofenadine: new preparation. Terfenadine, without cardiotoxicity.
    Prescrire Int; 1999 Feb; 8(39):11-3. PubMed ID: 10557567
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-sedating antihistamines in the treatment of chronic idiopathic urticaria using patient-reported outcomes.
    Grob JJ; Lachapelle JM
    Curr Med Res Opin; 2008 Aug; 24(8):2423-8. PubMed ID: 18651988
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Validation of the Dermatology Life Quality Index as an outcome measure for urticaria-related quality of life.
    Lennox RD; Leahy MJ
    Ann Allergy Asthma Immunol; 2004 Aug; 93(2):142-6. PubMed ID: 15328673
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of desloratadine in adults with chronic idiopathic urticaria: a randomized, double-blind, placebo-controlled, multicenter trial.
    Ortonne JP; Grob JJ; Auquier P; Dreyfus I
    Am J Clin Dermatol; 2007; 8(1):37-42. PubMed ID: 17298105
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of 60 mg twice-daily fexofenadine HCl on quality of life, work and classroom productivity, and regular activity in patients with chronic idiopathic urticaria.
    Thompson AK; Finn AF; Schoenwetter WF
    J Am Acad Dermatol; 2000 Jul; 43(1 Pt 1):24-30. PubMed ID: 10863219
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.